Results Seven studies involving 2241 patients were included. Two studies were considered to be at low risk of bias, three at high risk and two unclear risk of bias. Ibuprofen was found to be a superior analgesic to paracetamol at several doses, with high quality evidence suggesting that ibuprofen 400 mg is superior to 1000 mg paracetamol based on pain relief (estimated from TOTPAR data) and the use of rescue medication meta-analyses. Risk ratio (RR) for at least 50% pain relief (based on TOTPAR) at six hours was 1.47 (95% confidence interval (CI) 1.28 to 1.69; five trials) favouring 400 mg ibuprofen over 1000 mg paracetamol, RR for not using rescue medication (also favouring ibuprofen) was 1.50 (95% CI 1.25 to 1.79; four trials).
For combined drug RR for at least 50% of the maximum pain relief over six hours of 1.77 (95% CI 1.32 to 2.39) (paracetamol 1000 mg and ibuprofen 400 mg) (one trial; moderate quality evidence). RR not using rescue medication 1.60 (95% CI 1.36 to 1.88) (two trials; moderate quality evidence). Adverse events were comparable between the treatment groups, but no formal analysis could be undertaken.
Conclusions There is high quality evidence that ibuprofen is superior to paracetamol at doses of 200 mg to 512 mg and 600 mg to 1000 mg respectively based on pain relief and use of rescue medication data collected at six hours postoperatively. The majority of this evidence (five The wide use of narcotics has been a topic for discussion. A recent survey/study, sent to a small group of oral surgeons in Canada and the US, reflects that narcotics are still prescribed (hydrocodone and codeine) after surgical procedures. A small percentage will prescribe NSAIDs only. 1 There is a rising trend to decrease the amount of narcotics prescribed due to the undesirable side effects. This is why this is a clinically relevant topic as to assessing the use of non-narcotic analgesics. The review had a specific question which was to find the best strategy for pain relief following wisdom teeth extraction based on the nature of this surgical procedure. Pain relief was assessed at different intervals and doses of ibuprofen, paracetamol and combinations in one pill.
As a Cochrane review, it was conducted with an appropriate methodology, only English databases were searched, a thorough critical appraisal was performed. A grade of the evidence for each outcome was presented using GRADEprofiler, summarising the findings, quality of evidence and strength of the recommendations. Clinically, the challenge is that the combination pill is not available in all countries. This may impact the patients' cooperation since they may not wish to take multiple pills.
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